found that overexpression of the methyltransferase METTL3 was related to the poor prognosis of hepatocellular carcinoma, promoting its proliferation, migration, and lung metastasis through the m6A-dependent YTHDF2-SOCS2 pathway (43). This evidence concerns the gene METTL3 and hepatocellular carcinoma.